Andreja Rehberger Likozar
7PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Feb 26, 2025
Effect of PCSK9 Inhibitors on Regulators of Lipoprotein Homeostasis, Inflammation and Coagulation.Patricija Lunar, Hana Meglič, Mateja Vehar
|Feb 25, 2025
Treatment with PCSK9 inhibitors influences microRNAs expression and changes of arterial wall properties: a randomized controlled trial.Andreja Rehberger Likozar, Tina Levstek, Tina Karun
|Jan 23, 2024
Haplotype of the Lipoprotein(a) Gene Variants rs10455872 and rs3798220 Is Associated with Parameters of Coagulation, Fibrinolysis, and Inflammation in Patients after Myocardial Infarction and Highly Elevated Lipoprotein(a) Values.Sabina Ugovšek, Andreja Rehberger Likozar, Tina Levstek
|Mar 29, 2023
Interplay between microRNAs, Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9), and Lipid Parameters in Patients with Very High Lipoprotein(a) Treated with PCSK9 Inhibitors.Tina Levstek, Tina Karun, Andreja Rehberger Likozar
|Jul 25, 2022
Gene Expression Profiling of Markers of Inflammation, Angiogenesis, Coagulation and Fibrinolysis in Patients with Coronary Artery Disease with Very High Lipoprotein(a) Levels Treated with PCSK9 Inhibitors.Katja Hrovat, Andreja Rehberger Likozar, Janja Zupan
|Jul 20, 2022
Pharmacologic modulation of intracellular Na+ concentration with ranolazine impacts inflammatory response in humans and mice.Max Lenz, Manuel Salzmann, Cosmin I Ciotu
Pageof 2
Frequent Collaborators
6 joint publications
Miran Šebeštjen
3 joint publications
Tina Levstek
3 joint publications
Katarina Trebušak Podkrajšek
3 joint publications
Janja Zupan
2 joint publications
Sabina Ugovšek
1 joint publications
Max Lenz
1 joint publications
Manuel Salzmann
1 joint publications
Christoph Kaun
1 joint publications
Laura Goederle
1 joint publications
Zoriza Krivaja
